Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Durvalumab industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Medimmune (AstraZeneca)
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
24mL Injection
10mL Injection
Application:
Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Durvalumab Industry Overview
-
1.1.1 Durvalumab Market Scope and Market Segments
-
1.1.2 Durvalumab Industry Characteristics
-
1.1.3 Global and China Durvalumab Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Durvalumab Production Value and Growth Rate (2017-2028)
-
1.2 Global Durvalumab Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 24mL Injection
-
1.2.2 10mL Injection
-
1.3 Global Durvalumab Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Locally Advanced Urothelial Carcinoma
-
1.3.2 Metastatic Urothelial Carcinoma
-
1.3.3 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Durvalumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Durvalumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Durvalumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Durvalumab Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Durvalumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Durvalumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Durvalumab Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Durvalumab Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Durvalumab Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Durvalumab Industry Porter's Five Forces Model Analysis
-
2.2.3 Durvalumab Industry PEST Analysis
-
2.3 Durvalumab Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Durvalumab Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Durvalumab Industry
Chapter 3 Global and China Durvalumab Market, by Manufacturer
-
3.1 Global and China Durvalumab Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Durvalumab Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Durvalumab Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Durvalumab Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Durvalumab Market Top 3 Players
Chapter 4 Global and China Durvalumab Market, by Type (2017-2028)
-
4.1 Durvalumab Market Trend, by Type
-
4.2 Global Durvalumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Durvalumab Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Durvalumab Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Durvalumab Price Trend, by Type (2017-2028)
-
4.3 China Durvalumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Durvalumab Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Durvalumab Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Durvalumab Price Trend, by Type (2017-2028)
Chapter 5 Global and China Durvalumab Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Durvalumab Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Durvalumab Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Durvalumab Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Durvalumab Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Durvalumab Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Durvalumab Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Durvalumab Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Durvalumab Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Durvalumab Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Durvalumab Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Durvalumab Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Durvalumab Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Durvalumab Market Analysis
-
7.1 North America Durvalumab Market, by Type
-
7.2 North America Durvalumab Market, by Application
-
7.3 North America Durvalumab Market Analysis and Forecast, by Country
-
7.3.1 United States Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Durvalumab Market Analysis
-
8.1 Europe Durvalumab Market, by Type
-
8.2 Europe Durvalumab Market, by Application
-
8.3 Europe Durvalumab Market Analysis and Forecast, by Country
-
8.3.1 Germany Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Durvalumab Market Analysis
-
9.1 APAC Durvalumab Market, by Type
-
9.2 APAC Durvalumab Market, by Application
-
9.3 APAC Durvalumab Market Analysis and Forecast, by Country
-
9.3.1 China Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Durvalumab Market Analysis
-
10.1 Latin America, Middle East and Africa Durvalumab Market, by Type
-
10.2 Latin America, Middle East and Africa Durvalumab Market, by Application
-
10.3 Latin America, Middle East and Africa Durvalumab Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Durvalumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Durvalumab Company Profiles
-
11.1 Medimmune (AstraZeneca)
-
11.1.1 Medimmune (AstraZeneca) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Medimmune (AstraZeneca) Durvalumab Product Profiles, Application and Specification
-
11.1.3 Medimmune (AstraZeneca) Durvalumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Durvalumab Industry Investment Prospect and Risk Assessment
-
12.1 Durvalumab Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Durvalumab Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Global Durvalumab Production Value and Growth Rate (2017-2028)
-
Figure China Durvalumab Production Value and Growth Rate (2017-2028)
-
Figure Global Durvalumab Market Size and Growth Rate of 24mL Injection (2017-2028)
-
Figure Global Durvalumab Market Size and Growth Rate of 10mL Injection (2017-2028)
-
Figure Global Durvalumab Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma (2017-2028)
-
Figure Global Durvalumab Market Size and Growth Rate of Metastatic Urothelial Carcinoma (2017-2028)
-
Figure Global Durvalumab Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Durvalumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Durvalumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Durvalumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Durvalumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Durvalumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Durvalumab Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Durvalumab Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Durvalumab Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Durvalumab Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Durvalumab Market Share, by Manufacturer in 2021
-
Figure Global and China Durvalumab Market Share, by Manufacturer in 2022
-
Table Global Durvalumab Sales Volume, by Type (2017-2028)
-
Table Global Durvalumab Sales Volume Share, by Type (2017-2028)
-
Figure Global Durvalumab Sales Volume Share, by Type (2017-2028)
-
Table Global Durvalumab Sales Value, by Type (2017-2028)
-
Table Global Durvalumab Sales Value Share, by Type (2017-2028)
-
Figure Global Durvalumab Price Trend, by Type (2017-2028)
-
Table China Durvalumab Sales Volume, by Type (2017-2028)
-
Table China Durvalumab Sales Volume Share, by Type (2017-2028)
-
Figure China Durvalumab Sales Volume Share, by Type (2017-2028)
-
Table China Durvalumab Sales Value, by Type (2017-2028)
-
Table China Durvalumab Sales Value Share, by Type (2017-2028)
-
Figure China Durvalumab Price Trend, by Type (2017-2028)
-
Table Global Durvalumab Sales Volume, by Application (2017-2028)
-
Table Global Durvalumab Sales Volume Share, by Application (2017-2028)
-
Figure Global Durvalumab Sales Volume Share, by Application (2017-2028)
-
Table Global Durvalumab Sales Value, by Application (2017-2028)
-
Table Global Durvalumab Sales Value Share, by Application (2017-2028)
-
Figure Global Durvalumab Sales Value Share, by Application (2017-2028)
-
Table China Durvalumab Sales Volume, by Application (2017-2028)
-
Table China Durvalumab Sales Volume Share, by Application (2017-2028)
-
Figure China Durvalumab Sales Volume Share, by Application (2017-2028)
-
Table China Durvalumab Sales Value, by Application (2017-2028)
-
Table China Durvalumab Sales Value Share, by Application (2017-2028)
-
Figure China Durvalumab Sales Value Share, by Application (2017-2028)
-
Figure China Durvalumab Production, Import, Consumption and Export (2017-2022)
-
Figure North America Durvalumab Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Durvalumab Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Durvalumab Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Durvalumab Production, Import, Consumption and Export (2017-2022)
-
Table North America Durvalumab Sales Volume, by Type (2017-2028)
-
Table North America Durvalumab Sales Volume Share, by Type (2017-2028)
-
Figure North America Durvalumab Sales Volume Share, by Type (2017-2028)
-
Table North America Durvalumab Sales Volume, by Application (2017-2028)
-
Table North America Durvalumab Sales Volume Share, by Application (2017-2028)
-
Figure North America Durvalumab Sales Volume Share, by Application (2017-2028)
-
Figure United States Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure United States Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Canada Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Durvalumab Sales Value and Growth Rate (2017-2028)
-
Table Europe Durvalumab Sales Volume, by Type (2017-2028)
-
Table Europe Durvalumab Sales Volume Share, by Type (2017-2028)
-
Figure Europe Durvalumab Sales Volume Share, by Type (2017-2028)
-
Table Europe Durvalumab Sales Volume, by Application (2017-2028)
-
Table Europe Durvalumab Sales Volume Share, by Application (2017-2028)
-
Figure Europe Durvalumab Sales Volume Share, by Application (2017-2028)
-
Figure Germany Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure UK Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure UK Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure France Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure France Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Italy Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Spain Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Poland Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Russia Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Durvalumab Sales Value and Growth Rate (2017-2028)
-
Table APAC Durvalumab Sales Volume, by Type (2017-2028)
-
Table APAC Durvalumab Sales Volume Share, by Type (2017-2028)
-
Figure APAC Durvalumab Sales Volume Share, by Type (2017-2028)
-
Table APAC Durvalumab Sales Volume, by Application (2017-2028)
-
Table APAC Durvalumab Sales Volume Share, by Application (2017-2028)
-
Figure APAC Durvalumab Sales Volume Share, by Application (2017-2028)
-
Figure China Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Japan Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure India Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure India Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Durvalumab Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Durvalumab Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Durvalumab Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Durvalumab Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Durvalumab Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Durvalumab Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Durvalumab Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Durvalumab Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Durvalumab Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Durvalumab Sales Value and Growth Rate (2017-2028)
-
Table Medimmune (AstraZeneca) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Medimmune (AstraZeneca) Product Profiles, Application and Specification
-
Table Medimmune (AstraZeneca) Durvalumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
